After PD10 column purification, the integrity was evaluated by high-performance liquid chromatography (HPLC) and sodium dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and the immunoreactivity by a cell-binding assay.
Conjugates were analysed by ITLC for labelling efficiency and radiochemical purity, by HPLC and SDS-PAGE followed by phosphor imager analysis for integrity and by a cell-binding assay for immunoreactivity.
Immunoreactivity was determined by a cell-binding assay, 3 h at 37°C or overnight at 4°C.
All conjugates were analysed by instant thin-layer chromatography (ITLC) and HPLC, by SDS-polyacrylamide gel electrophoresis (PAGE) followed by phosphor imager analysis for integrity, and by a cell-binding assay for immunoreactivity.
The αvß3-targeting bioconjugate NODIA-Me-c RGDfK) was evaluated iNODIA-Me-c RGDfKpetitive cell biNODIA-Me-c RGDfKlowas by small-animal Pevaluatedg and ex vino biodistribution studies.
By using a host cell binding assay, recombinant SWP26 protein (rSWP26) can inhibit spore adherence by 10%, resulting in decreased host cell infection.
We previously reported that the immunogenicity of Hcβtre, a botulinum neurotoxin A (BoNT/A) immunogen, was enhanced by fusion to an epithelial cell binding domain, Ad2F, when nasally delivered to mice with cholera toxin (CT).
In this study, we employed a two-step aptamer selection strategy, comprised of a recombinant protein-based selection from the library followed by a cell-based binding screening for the selection of a thioaptamer to E-selectin.
Some molecules like integrins, focal adhesion proteins, and the cytoskeleton in the context of a complex cell structure when activated by cell binding to the ECM associate with the skeletal scaffold via the focal adhesion complex.
